ValueinValuein

PTIXProtagenic Therapeutics, Inc.\new

Health Care

Net Cash Provided by (Used in) Operating Activities revised down 50.0% for Q1 2025

This is the 6th largest revision in PTIX's history.

Net Cash Provided by (Used in) Operating Activities·Q1 2025

Major restatement
-$1.8M 50.0%

was-$1.2M

Revised down in a 10-Q.

No amendment filed
As reported · Sep 10, 202510-Q · Aug 19, 2026us-gaap:NetCashProvidedByUsedInOperatingActivities
Verify against SEC filingsShow
As reported-$1.2M
Accepted 2025-09-100001641172-25-027041
Restated-$1.8M
Accepted 2026-08-190001493152-26-039221

OperatingCashFlow · reported 2 times · point-in-time, survivorship-free. Every figure traces to its filing above.

Track this the moment it happens

Get a signal the next time PTIX — or any company on your watchlist — restates a number. Every signal lands with the diff and its source filing.

Restatement — Valuein Radar | Valuein